(BAS) BASF SE - Ratings and Ratios
Chemicals, Materials, Coatings, Crop Protection, Nutrition Ingredients
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 5.16% |
| Yield on Cost 5y | 4.71% |
| Yield CAGR 5y | 0.75% |
| Payout Consistency | 94.3% |
| Payout Ratio | 71.2% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 23.3% |
| Value at Risk 5%th | 36.8% |
| Relative Tail Risk | -4.27% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.27 |
| Alpha | -1.36 |
| CAGR/Max DD | 0.00 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.394 |
| Beta | 0.320 |
| Beta Downside | 0.382 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.19% |
| Mean DD | 11.37% |
| Median DD | 11.81% |
Description: BAS BASF SE December 03, 2025
BASF SE (XETRA:BAS) is a globally diversified chemical producer organized into six business segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care, and Agricultural Solutions. The Chemicals segment supplies petrochemicals and intermediates, while Materials focuses on advanced polymers and precursors such as isocyanates and polyamides. Industrial Solutions markets additives and resins for automotive, construction, and electronics; Surface Technologies provides catalysts, battery materials, and coating services; Nutrition & Care delivers ingredients for food, personal care, and pharma; and Agricultural Solutions offers seeds, crop protection chemicals, and digital farming tools. The firm also engages in engineering services, equipment leasing, and commodity trading.
Key recent metrics: BASF reported €87.6 billion in revenue for FY 2023, with an adjusted EBITDA margin of roughly 9 %, reflecting pressure from elevated European energy costs and raw-material price volatility. The company’s strategic pivot toward higher-margin specialty chemicals and sustainable solutions is a primary growth driver, supported by its €2 billion “ChemCycling” initiative to recycle plastics and reduce carbon intensity. Macro-level, demand in the automotive and construction sectors-both cyclical and sensitive to interest-rate environments-continues to shape BASF’s top-line outlook, while the ongoing energy transition creates both cost challenges and opportunities in battery-material and green-chemistry segments.
For a deeper quantitative assessment of BASF’s valuation metrics and scenario analysis, the ValueRay platform offers a concise dashboard you may find useful.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (273.0m TTM) > 0 and > 6% of Revenue (6% = 3.80b TTM) |
| FCFTA 0.00 (>2.0%) and ΔFCFTA -1.89pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 25.00% (prev 22.57%; Δ 2.43pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 5.43b > Net Income 273.0m (YES >=105%, WARN >=100%) |
| Net Debt (20.92b) to EBITDA (7.24b) ratio: 2.89 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.92 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (892.5m) change vs 12m ago 0.0% (target <= -2.0% for YES) |
| Gross Margin 25.75% (prev 25.54%; Δ 0.21pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 81.33% (prev 82.25%; Δ -0.92pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.26 (EBITDA TTM 7.24b / Interest Expense TTM 1.14b) >= 6 (WARN >= 3) |
Altman Z'' 3.59
| (A) 0.21 = (Total Current Assets 33.09b - Total Current Liabilities 17.25b) / Total Assets 76.44b |
| (B) 0.39 = Retained Earnings (Balance) 29.91b / Total Assets 76.44b |
| (C) 0.03 = EBIT TTM 2.58b / Avg Total Assets 77.90b |
| (D) 0.70 = Book Value of Equity 29.62b / Total Liabilities 42.53b |
| Total Rating: 3.59 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 43.53
| 1. Piotroski 4.0pt |
| 2. FCF Yield 0.50% |
| 3. FCF Margin 0.47% |
| 4. Debt/Equity 0.70 |
| 5. Debt/Ebitda 2.89 |
| 6. ROIC - WACC (= 0.34)% |
| 7. RoE 0.80% |
| 8. Rev. Trend -85.14% |
| 9. EPS Trend -11.83% |
What is the price of BAS shares?
Over the past week, the price has changed by -1.98%, over one month by -1.56%, over three months by +1.84% and over the past year by +8.57%.
Is BAS a buy, sell or hold?
What are the forecasts/targets for the BAS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 47.8 | 9.6% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 45.9 | 5.2% |
BAS Fundamental Data Overview December 21, 2025
Market Cap EUR = 39.06b (39.06b EUR * 1.0 EUR.EUR)
P/E Trailing = 128.7059
P/E Forward = 21.9298
P/S = 0.6074
P/B = 1.2129
P/EG = 1.3382
Beta = 0.923
Revenue TTM = 63.35b EUR
EBIT TTM = 2.58b EUR
EBITDA TTM = 7.24b EUR
Long Term Debt = 18.93b EUR (from longTermDebt, last quarter)
Short Term Debt = 3.85b EUR (from shortTermDebt, last quarter)
Debt = 22.78b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 20.92b EUR (from netDebt column, last quarter)
Enterprise Value = 59.98b EUR (39.06b + Debt 22.78b - CCE 1.86b)
Interest Coverage Ratio = 2.26 (Ebit TTM 2.58b / Interest Expense TTM 1.14b)
FCF Yield = 0.50% (FCF TTM 298.0m / Enterprise Value 59.98b)
FCF Margin = 0.47% (FCF TTM 298.0m / Revenue TTM 63.35b)
Net Margin = 0.43% (Net Income TTM 273.0m / Revenue TTM 63.35b)
Gross Margin = 25.75% ((Revenue TTM 63.35b - Cost of Revenue TTM 47.04b) / Revenue TTM)
Gross Margin QoQ = 22.06% (prev 26.50%)
Tobins Q-Ratio = 0.78 (Enterprise Value 59.98b / Total Assets 76.44b)
Interest Expense / Debt = 1.16% (Interest Expense 264.0m / Debt 22.78b)
Taxrate = -20.71% (negative due to tax credits) (-29.0m / 140.0m)
NOPAT = 3.11b (EBIT 2.58b * (1 - -20.71%)) [negative tax rate / tax credits]
Current Ratio = 1.92 (Total Current Assets 33.09b / Total Current Liabilities 17.25b)
Debt / Equity = 0.70 (Debt 22.78b / totalStockholderEquity, last quarter 32.76b)
Debt / EBITDA = 2.89 (Net Debt 20.92b / EBITDA 7.24b)
Debt / FCF = 70.21 (Net Debt 20.92b / FCF TTM 298.0m)
Total Stockholder Equity = 34.20b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.36% (Net Income 273.0m / Total Assets 76.44b)
RoE = 0.80% (Net Income TTM 273.0m / Total Stockholder Equity 34.20b)
RoCE = 4.85% (EBIT 2.58b / Capital Employed (Equity 34.20b + L.T.Debt 18.93b))
RoIC = 5.39% (NOPAT 3.11b / Invested Capital 57.66b)
WACC = 5.06% (E(39.06b)/V(61.84b) * Re(7.19%) + D(22.78b)/V(61.84b) * Rd(1.16%) * (1-Tc(-0.21)))
Discount Rate = 7.19% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -0.01%
[DCF Debug] Terminal Value 73.59% ; FCFE base≈903.2m ; Y1≈686.8m ; Y5≈421.3m
Fair Price DCF = 8.88 (DCF Value 7.93b / Shares Outstanding 892.5m; 5y FCF grow -28.43% → 3.0% )
EPS Correlation: -11.83 | EPS CAGR: -19.45% | SUE: 0.21 | # QB: 0
Revenue Correlation: -85.14 | Revenue CAGR: -8.23% | SUE: -0.17 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.10 | Chg30d=+0.000 | Revisions Net=+0 | Analysts=2
EPS next Year (2026-12-31): EPS=2.73 | Chg30d=-0.083 | Revisions Net=-2 | Growth EPS=+3.2% | Growth Revenue=+1.7%